- Home
- OST vs PMN Comparison
OST vs PMN Comparison
Compare OST & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- PMN
- Stock Information
- Founded
- OST 2010
- PMN 2004
- Country
- OST China
- PMN Canada
- Employees
- OST N/A
- PMN N/A
- Industry
- OST Industrial Machinery/Components
- PMN Pharmaceuticals and Biotechnology
- Sector
- OST Technology
- PMN Health Care
- Exchange
- OST Nasdaq
- PMN Nasdaq
- Market Cap
- OST 15.7M
- PMN 16.0M
- IPO Year
- OST 2022
- PMN N/A
- Fundamental
- Price
- OST $0.10
- PMN $0.90
- Analyst Decision
- OST
- PMN Strong Buy
- Analyst Count
- OST 0
- PMN 3
- Target Price
- OST N/A
- PMN $4.33
- AVG Volume (30 Days)
- OST 36.1M
- PMN 21.2M
- Earning Date
- OST 08-25-2025
- PMN 08-07-2025
- Dividend Yield
- OST N/A
- PMN N/A
- EPS Growth
- OST N/A
- PMN N/A
- EPS
- OST N/A
- PMN N/A
- Revenue
- OST $38,333,251.00
- PMN N/A
- Revenue This Year
- OST N/A
- PMN N/A
- Revenue Next Year
- OST N/A
- PMN N/A
- P/E Ratio
- OST N/A
- PMN N/A
- Revenue Growth
- OST 0.34
- PMN N/A
- 52 Week Low
- OST $0.10
- PMN $0.38
- 52 Week High
- OST $9.40
- PMN $1.75
- Technical
- Relative Strength Index (RSI)
- OST 25.01
- PMN 62.44
- Support Level
- OST $0.10
- PMN $0.77
- Resistance Level
- OST $0.13
- PMN $1.06
- Average True Range (ATR)
- OST 0.01
- PMN 0.19
- MACD
- OST 0.17
- PMN 0.05
- Stochastic Oscillator
- OST 7.00
- PMN 42.98
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.